Wanli Tang represents pharmaceutical and biotechnology companies of all sizes on the procurement and protection of intellectual property. She develops and manages global patent portfolios for her clients and coordinates strategies to meet clients' IP needs and business goals. Wanli counsels on issues including patentability, validity, enforceability, infringement, and freedom-to-operate. She also assists client with investment- and public offering-related diligence investigations.Wanli conducts prelitigation analyses and represents clients in offensive and defensive post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), including inter partes reviews (IPRs). She works closely with expert witnesses in preparation for depositions or declarations, coordinates document discovery, and drafts petitions and briefings.